RECENT NEWS

Faster and cheaper production of new antibiotics

Faster and cheaper production of new antibiotics

A novel way of synthesising a promising new antibiotic has been identified by scientists at the University of Bristol. By expressing the genes involved in the production of pleuromutilin in a different type of fungus, the researchers have been able to increase production by more than 2000%. CDC/Melissa Dankel; James Gathany.jpg
Official opening of the new South West London Pathology laboratories

Official opening of the new South West London Pathology laboratories

Institute President Ian Sturdgess recently attended the launch of South West London Pathology’s new state-of-the-art laboratories at St George’s Hospital NHS Foundation Trust. Ian was invited along with guests from South West London Pathology (SWLP) staff, hospital trusts, NHS England, the Medical Director for London Region, local GPs and CCG colleagues, and representatives from commercial companies.
Highlighting healthcare-associated infection

Highlighting healthcare-associated infection

To coincide with World Health Day, decontamination and infection control specialist Hygiene Solutions has produced an infographic to highlight healthcare-associated infections (HAIs) – what they are and how they spread – and what healthcare professionals and members of the public can do to help avoid the transmission of HAIs. The infographic, which can be viewed at the link below, is designed help spread awareness of HAIs such as Clostridium difficile (pictured) and how they can be contained and prevented.
Institute Fellow appointed Deputy Lieutenant of Greater London

Institute Fellow appointed Deputy Lieutenant of Greater London

Institute Fellow Dr Mustafa A Abu-Lisan has been appointed Deputy Lieutenant of Greater London in the Royal Borough of Kensington & Chelsea. Dr Abu-Lisan was appointed to the post by Her Majesty's Lord Lieutenant of Greater London, Kenneth Olisa.
Recognised in Healthcare Science Awards

Recognised in Healthcare Science Awards

Frances Hughes and Claire Swift, both senior biomedical scientists in molecular pathology, are part of the team at University Hospitals Birmingham NHS Foundation Trust which won the award for Improving Quality and Efficiency through Workforce Transformation, for their work on the Molecular Pathology Diagnostic Service.

Mast exhibiting at BSMT

Mast will be exhibiting again at the BSMT Spring Meeting, to be held at Public Health England, Colindale, on Friday, 20 May 2016. The one-day symposium ‘Assessing the Impact of New Technology in Diagnostics on Global Epidemiology: How Laboratories Make a Difference’, will discuss how laboratories identify and quantify infectious disease globally and how advances in technology has permitted more accurate reporting.

Ceftaroline AST discs and CLSI and EUCAST

Ceftaroline (Zinforo), manufactured by AstraZeneca, is a novel cephalosporin used in the treatment of skin and soft tissue infections. It has also been used successfully in the treatment of complicated skin infections.
Myocardial infarction: improved detection in women

Myocardial infarction: improved detection in women

Abbott’sARCHITECT STATHigh Sensitive Troponin-I (hsTnI) test may help clinicians detect twice as many cases of myocardial infarction (MI) in women. Results have shown that the test is able todiagnose an MI in 22% of cases for women compared to a standard of 11% when usinga gender-specific threshold (an approach to setting diagnostic thresholds which tailors treatment andtest thresholds by gender). https://en.wikipedia.org/wiki/File:Heart_ant_wall_infarction.jpg
Early warning of skin cancer relapse

Early warning of skin cancer relapse

A blood test may be able to provide early warning that patients with advanced melanoma skin cancer are relapsing, according to a study published recently in Cancer Discovery(Girotti MR, Gremel G, Lee R et al. Application of sequencing, liquid biopsies and patient-derived xenografts for personalized medicine in melanoma.Cancer Discov 2015 Dec 29. Pii: CD-15-1336 [Epub ahead of print]).
Transforming healthcare from Northern Ireland

Transforming healthcare from Northern Ireland

From its headquarters in Crumlin, Northern Ireland, Randox has grown into an international success story, at the frontline of improving healthcare in conditions such as stroke, dementia, diabetes, heart disease, sexually transmitted infections (STIs) and respiratory infections through earlier and more accurate diagnosis.
Patient Sample and Request Form Identification Criteria

Patient Sample and Request Form Identification Criteria

The IBMS has published updated guidance on Patient Sample and Request Form Identification Criteria. The updated policy defines the minimum criteria that must be in place for the receipt and identification of samples. 
Innovative research supported by SET Award

Innovative research supported by SET Award

IBMS President Ian Sturdgess joined the Parliamentary and Scientific Committee, MPs and scientists in Parliament recently to present the Silver Award in Biological and Biomedical Sciences at SET for Britain 2016.
Post-prandial glucose control

Post-prandial glucose control

New data from four studies demonstrate that post-prandial hyperglycaemia is associated with a negative physical and emotional impact on people with type 1 and type 2 diabetes, greater use of healthcare resources, missed work time and reduced productivity. These results were presented recently at the World Diabetes Congress of the International Diabetes Federation.
David Bennett moves to Viapath

David Bennett moves to Viapath

Dr David Bennett, former head of NHS Foundation Trust regulator Monitor, has been appointed the new Chair of Viapath, the pathology joint venture owned by Guy’s and St Thomas’, King’s College Hospital and Serco.
Cancer immunotherapy using patients’ T cells

Cancer immunotherapy using patients’ T cells

An international team of scientists has reported important results using patients' own immune cells to fight cancer. In one trial, symptoms disappeared in 94% of patients with acute lymphoblastic leukaemia. In other types of blood cancer, response rates over 80% have been reported, and over half experienced complete remission. www.nih.gov
Need to identify clinical anaerobes? Apply for your free guide

Need to identify clinical anaerobes? Apply for your free guide

An Introduction to Clinical Anaerobic Bacteriology is a special guide that enables readers to isolate and identify 12 commonly occurring, clinically important anaerobic bacteria. Don Whitley Scientific is offering UK-based readers a free copy of the Library Edition of this publication. To apply for your free copy, please email the company or log on to its website and complete the contact form.
Green Apple Environmental Award for pipette tip racks

Green Apple Environmental Award for pipette tip racks

Rainin TerraRack pipette tip racks have achieved success in last year’s Green Apple Awards. The judges recognised the environmental benefits of this product range – which is designed to minimise the problem of plastic tip rack waste – selecting TerraRack from a field of more than 500 entries to receive a Bronze Award for Environmental Best Practice. The award was presented to EU market manager Ian Eaton-Taylor at a ceremony held at the Houses of Parliament last November.
Flow cytometer awarded for innovative research

Flow cytometer awarded for innovative research

An internationally renowned gene therapy research team has won a $200,000 CytoFLEX flow cytometer from Beckman Coulter Life Sciences. The contest was designed to explore innovative research solutions involving flow cytometry. The winning team, headed by Dr Martin Pulé, is from the UCL Cancer Institute at University College London.
Services to Public Health recognised

Services to Public Health recognised

Neil Bentley, head of Specialist Microbiology Technical Services at Public Health England (PHE), has been awarded an OBE for Services to Public Health in the New Year's Honours, which is well-deserved recognition of his contribution to public health in the UK and overseas. 
Improved prostate cancer screening

Improved prostate cancer screening

A study undertaken in Sweden has shown that a new test for prostate cancer is better at detecting aggressive cancer than prostate-specific antigen (PSA). The new test, which has undergone trial in 58,818 men, discovered aggressive cancer earlier and reduced the number of false-positive tests and unnecessary biopsies. The results were published recently in the The Lancet Oncology.

Upcoming Events

Update Course in Gynaecological Cytology

London Regional Cytology Training Centre, Level 6X, St Marks Building, Watford Road, Harrow HA1 3UJ
12-14 December 2018

Managing Cultural Differences in the Workplace

The Holiday Inn - Kensington Forum, 97 Cromwell Road, London SW7 4DN
21 January 2019

British Society for Haematology Paediatric Symposium

Royal College of Paediatrics and Child Health, 5-11 Theobalds Road, London WC1X 8SH
14 February 2019

Challenges in the clinical biochemistry laboratory and beyond

The Royal College of Pathologists
28 February 2019

British Society for Haematology 59th Annual Scientific Meeting

SEC Glasgow
1-3 April 2019

Latest Issue

Pathology In Practice

Pathology In Practice

Dec 2018

Molecular diagnostics and LAMP technology

Register now to apply for regular copies of Pathology In Practice and free access to premium content, as well as our regular newsletters.